Sign in

CIK 0001070494 · Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
061376651
Phone
858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. DEF 14A Proxy Proxy Statement
  2. 8-K Event Regulation FD disclosure · Other events
  3. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  4. 8-K Event Other events
  5. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 10-K Report Annual Report
  12. 8-K Event Results of operations
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13G/A Stake Amended Statement of Ownership
  15. 4 Open-market sale EVP and CFO sold 2,051 shares at $50.61 ($103,801)
  16. 4 Open-market sale CEO sold 14,195 shares at $50.61 ($718,409)
  17. 4 Open-market sale President sold 8,429 shares at $50.61 ($426,592)
  18. 4 Open-market sale EVP & General Counsel sold 2,107 shares at $50.61 ($106,635)
  19. SC 13G/A Stake Amended Statement of Ownership
  20. 8-K Event Executive or director change

Page 19 of 70 · 1,382 filings